Log in

CVE:EKGCardioComm Solutions Stock Price, Forecast & News

Today's Range N/A
50-Day Range
MA: C$0.04
52-Week Range N/A
Volume16,975 shs
Average Volume83,254 shs
Market CapitalizationC$4.25 million
P/E RatioN/A
Dividend YieldN/A
CardioComm Solutions, Inc., together with its subsidiary, CardioView Inc., develops software and hardware products, and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets worldwide. Its technology is used in a range of products for the recording, transmission, viewing, analyzing, reporting, and storage of ECGs for arrhythmia screening, diagnosis, and management of cardiac patients. The company's software products include Global ECG Management System (GEMS), a software solution for cardiac event monitoring; GlobalCardio 12 Lead, a Web enabled ECG device that is EMR compatible; and GEMS Lite for Windows, an electronic ECG receiving system. It also offers software modules, such as GEMS WIN Air, a live wireless ECG monitoring solution; AutoAttendant, which allows healthcare providers to focus on providing patient care; GEMS HL7 and EMR Interface that allows patient and follow-up information to be sent in an HL7 message format to other EMR systems that are HL7 compliant; and GlobalCardio EMR integration that enables bidirectional movement of data, including patient information, reports, and links. In addition, the company provides hardware products comprising HeartCheck PEN and HeartCheck, a handheld ECG monitor; and Sirona telephonic and wireless event recorders. Further, it offers ASP services, including C4 ECG management services; and HeartCheck SMART Monitoring, an ECG reading service, as well as provides other products comprising GlobalCardio 3 Lead; ECG Viewer SDK; QRS Diagnostic; and QRS 12 Lead Universal products. The company sells its products to medical professionals, patients, healthcare professionals, ECG commercial reading services, physicians, hospitals through a combination of an external distribution network and a North American-based sales team. CardioComm Solutions, Inc. was incorporated in 1989 and is headquartered in Toronto, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.50 out of 5 stars

Industry, Sector and Symbol

Industry Health Information Services



Sales & Book Value

Annual SalesC$856,766.00
Book ValueC($0.01) per share



Market CapC$4.25 million
Next Earnings DateN/A
OptionableNot Optionable
30 days | 90 days | 365 days | Advanced Chart

Receive EKG News and Ratings via Email

Sign-up to receive the latest news and ratings for EKG and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

CardioComm Solutions (CVE:EKG) Frequently Asked Questions

Has CardioComm Solutions been receiving favorable news coverage?

Media headlines about EKG stock have trended positive recently, according to InfoTrie Sentiment. The research group scores the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. CardioComm Solutions earned a news impact score of 2.8 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company's share price in the near future.
View the latest news about CardioComm Solutions

Who are some of CardioComm Solutions' key competitors?

Who are CardioComm Solutions' key executives?

CardioComm Solutions' management team includes the following people:
  • Mr. Etienne Grima, CEO, Corp. Sec. & Director
  • Mr. Simi Grosman, Consultant & Director
  • Ms. Anne Burpee, Chief Financial Officer

What is CardioComm Solutions' stock symbol?

CardioComm Solutions trades on the Canadian Venture Exchange (CVE) under the ticker symbol "EKG."

How do I buy shares of CardioComm Solutions?

Shares of EKG and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

How big of a company is CardioComm Solutions?

CardioComm Solutions has a market capitalization of C$0.00 and generates C$856,766.00 in revenue each year.

What is CardioComm Solutions' official website?

The official website for CardioComm Solutions is www.cardiocommsolutions.com.

How can I contact CardioComm Solutions?

CardioComm Solutions' mailing address is 259 Yorkland Rd 2nd Floor, NORTH YORK, ON M2J 0B5, Canada. The company can be reached via phone at +1-416-9779425.

This page was last updated on 8/11/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.